183 related articles for article (PubMed ID: 31528120)
1. Combined high expression of CD47 and CD68 is a novel prognostic factor for breast cancer patients.
Yuan J; He H; Chen C; Wu J; Rao J; Yan H
Cancer Cell Int; 2019; 19():238. PubMed ID: 31528120
[TBL] [Abstract][Full Text] [Related]
2. CD47 and CD68 expression in breast cancer is associated with tumor-infiltrating lymphocytes, blood vessel invasion, detection mode, and prognosis.
Chen Y; Klingen TA; Aas H; Wik E; Akslen LA
J Pathol Clin Res; 2023 May; 9(3):151-164. PubMed ID: 36598153
[TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of combined high expression of CD47 and MCT1 in breast cancer: a retrospective study during a 10-year period.
Sun Y; Liang S; Li T; Peng C; Yang Y; Lin Y; Ma Y; Dong C
Transl Cancer Res; 2022 Jan; 11(1):29-42. PubMed ID: 35261882
[TBL] [Abstract][Full Text] [Related]
4. B7-H3 and CD47 co-expression in gastric cancer is a predictor of poor prognosis and potential targets for future dual-targeting immunotherapy.
Chen S; Zhan S; Ding S; Zhang Q; Xuan H; Zhang X; Cao L
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16609-16621. PubMed ID: 37715830
[TBL] [Abstract][Full Text] [Related]
5. Combination of CD47 and CD68 expression predicts survival in eastern-Asian patients with non-small cell lung cancer.
Fu F; Zhang Y; Gao Z; Zhao Y; Wen Z; Han H; Li Y; Hu H; Chen H
J Cancer Res Clin Oncol; 2021 Mar; 147(3):739-747. PubMed ID: 33392661
[TBL] [Abstract][Full Text] [Related]
6. Expression of CD47 and SIRPα Macrophage Immune-Checkpoint Pathway in Non-Small-Cell Lung Cancer.
Giatromanolaki A; Mitrakas A; Anestopoulos I; Kontosis A; Koukourakis IM; Pappa A; Panayiotidis MI; Koukourakis MI
Cancers (Basel); 2022 Apr; 14(7):. PubMed ID: 35406573
[TBL] [Abstract][Full Text] [Related]
7. Is overexpression of CD163 and CD47 in tumour cells of breast carcinoma implicated in the recruitment of tumour-associated macrophages (TAMs) in tumour microenvironment? immunohistochemical prognostic study.
Dawoud MM; Abd El Samie Aiad H; Kasem NS; El Khouly EA; Al-Sharaky DR
J Immunoassay Immunochem; 2024 May; ():1-20. PubMed ID: 38815282
[TBL] [Abstract][Full Text] [Related]
8. CD47 expression and tumor-associated immune cells in breast cancer and their correlation with molecular subtypes and prognostic factors.
Celepli P; Karabulut S; Bigat İ; Celepli S; Hücümenoğlu S
Pathol Res Pract; 2022 Oct; 238():154107. PubMed ID: 36088827
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature.
Zhao X; Qu J; Sun Y; Wang J; Liu X; Wang F; Zhang H; Wang W; Ma X; Gao X; Zhang S
Oncotarget; 2017 May; 8(18):30576-30586. PubMed ID: 28427165
[TBL] [Abstract][Full Text] [Related]
10. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients.
Medrek C; Pontén F; Jirström K; Leandersson K
BMC Cancer; 2012 Jul; 12():306. PubMed ID: 22824040
[TBL] [Abstract][Full Text] [Related]
11. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.
Pelekanou V; Villarroel-Espindola F; Schalper KA; Pusztai L; Rimm DL
Breast Cancer Res; 2018 Dec; 20(1):154. PubMed ID: 30558648
[TBL] [Abstract][Full Text] [Related]
12. CD68- and CD163-positive tumor infiltrating macrophages in non-metastatic breast cancer: a retrospective study and meta-analysis.
Ni C; Yang L; Xu Q; Yuan H; Wang W; Xia W; Gong D; Zhang W; Yu K
J Cancer; 2019; 10(19):4463-4472. PubMed ID: 31528210
[TBL] [Abstract][Full Text] [Related]
13. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
[TBL] [Abstract][Full Text] [Related]
14. Spatial distribution of tumor-resident macrophages as predictive biomarkers in endometrial cancer.
Matsukawa T; Yoshikawa N; Liu W; Hattori S; Yoshida K; Yoshihara M; Tamauchi S; Yokoi A; Niimi K; Kajiyama H
J Obstet Gynaecol Res; 2024 Apr; ():. PubMed ID: 38627199
[TBL] [Abstract][Full Text] [Related]
15. Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer.
Lu J; Xu Y; Wu Y; Huang XY; Xie JW; Wang JB; Lin JX; Li P; Zheng CH; Huang AM; Huang CM
BMC Cancer; 2019 Sep; 19(1):920. PubMed ID: 31521128
[TBL] [Abstract][Full Text] [Related]
16. Pathologic assessment of tumor-associated macrophages and their histologic localization in invasive breast carcinoma.
Mwafy SE; El-Guindy DM
J Egypt Natl Canc Inst; 2020 Jan; 32(1):6. PubMed ID: 32372332
[TBL] [Abstract][Full Text] [Related]
17. Expression and Prognostic Significance of CD47-SIRPA Macrophage Checkpoint Molecules in Colorectal Cancer.
Sugimura-Nagata A; Koshino A; Inoue S; Matsuo-Nagano A; Komura M; Riku M; Ito H; Inoko A; Murakami H; Ebi M; Ogasawara N; Tsuzuki T; Takahashi S; Kasugai K; Kasai K; Inaguma S
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33799989
[TBL] [Abstract][Full Text] [Related]
18. CD47 (don't eat me signal) expression levels and its relationship with clinicopathologic features in early-stage prostate carcinoma.
Semiz HS; Küçük Ü; Kısa E; Keskinkılıç M; Süyün DE; Arayıcı ME; Atağ E; Karaoglu A
Prostate; 2022 Dec; 82(16):1564-1571. PubMed ID: 36031743
[TBL] [Abstract][Full Text] [Related]
19. Targeting CD47 in Anaplastic Thyroid Carcinoma Enhances Tumor Phagocytosis by Macrophages and Is a Promising Therapeutic Strategy.
Schürch CM; Roelli MA; Forster S; Wasmer MH; Brühl F; Maire RS; Di Pancrazio S; Ruepp MD; Giger R; Perren A; Schmitt AM; Krebs P; Charles RP; Dettmer MS
Thyroid; 2019 Jul; 29(7):979-992. PubMed ID: 30938231
[No Abstract] [Full Text] [Related]
20. Tumor-associated Macrophages as Prognostic and Predictive Biomarkers for Postoperative Adjuvant Chemotherapy in Patients with Stage II Colon Cancer.
Feng Q; Chang W; Mao Y; He G; Zheng P; Tang W; Wei Y; Ren L; Zhu D; Ji M; Tu Y; Qin X; Xu J
Clin Cancer Res; 2019 Jul; 25(13):3896-3907. PubMed ID: 30988081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
